These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36251553)

  • 41. Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
    Slay RM; Hewitt JA; Crumrine M
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S411-S416. PubMed ID: 36251550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous anthrax: an overview.
    Celia F
    Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
    Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D
    Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical countermeasures to protect humans from anthrax bioterrorism.
    Bouzianas DG
    Trends Microbiol; 2009 Nov; 17(11):522-8. PubMed ID: 19781945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anthrax attack in the USA.
    McCarthy M
    Lancet Infect Dis; 2001 Dec; 1(5):288-9. PubMed ID: 11871791
    [No Abstract]   [Full Text] [Related]  

  • 49. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection.
    Hou AW; Morrill AM
    Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anthrax].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2001 Dec; 92(12):717-26. PubMed ID: 11822090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results.
    Xu W; Ohanjanian L; Sun J; Cui X; Suffredini D; Li Y; Welsh J; Eichacker PQ
    PLoS One; 2017; 12(8):e0182879. PubMed ID: 28797061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial therapy for anthrax.
    Torres-Tortosa M; Caballero-Granado FJ; Moreno I; Canueto J
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):696; author reply 697. PubMed ID: 12373508
    [No Abstract]   [Full Text] [Related]  

  • 54. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.
    Williams JL; Noviello SS; Griffith KS; Wurtzel H; Hamborsky J; Perz JF; Williams IT; Hadler JL; Swerdlow DL; Ridzon R
    Emerg Infect Dis; 2002 Oct; 8(10):1133-7. PubMed ID: 12396928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attacking anthrax.
    Young JA; Collier JR
    Sci Am; 2002 Mar; 286(3):48-50, 54-9. PubMed ID: 11857900
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anthrax due to deliberate infection].
    van Dissel JT; Kullberg BJ; van den Berg PC; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2366-71. PubMed ID: 11770263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel approaches to the treatment of systemic anthrax.
    Artenstein AW; Opal SM
    Clin Infect Dis; 2012 Apr; 54(8):1148-61. PubMed ID: 22438345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responding to the threat of bioterrorism: a microbial ecology perspective--the case of anthrax.
    Atlas RM
    Int Microbiol; 2002 Dec; 5(4):161-7. PubMed ID: 12497181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.